Area of research
Immunology · Oncology
Research interest
Research interests include Immunotherapy and Immune Responses, Immune Cell Function and Interaction, vaccines and immunoinformatics approaches, and Cancer Immunotherapy and Biomarkers.
STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition.
Supplementary Table 2 from STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Supplementary Table 1 from STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Data from STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Supplemental Figure 3 from STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Supplemental Figure 2 from STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Supplemental Figure 1 from STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Poly-ICLC, a multi-functional immune modulator for treating cancer.
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration.
Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw.
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma.
Double-Stranded RNA Immunomodulators in Prostate Cancer.
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model.
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice.
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer
Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
The PTEN pathway in T <sub>regs</sub> is a critical driver of the suppressive tumor microenvironment
Consensus nomenclature for CD8<sup>+</sup>T cell phenotypes in cancer
Transnuclear TRP1-Specific CD8 T Cells with High or Low Affinity TCRs Show Equivalent Antitumor Activity
Vaccine-Elicited CD8 <sup>+</sup> T Cells Protect against Respiratory Syncytial Virus Strain A2-Line19F-Induced Pathogenesis in BALB/c Mice
A Potent Vaccination Strategy That Circumvents Lymphodepletion for Effective Antitumor Adoptive T-cell Therapy
Novel Toll-like Receptor 2 Ligands for Targeted Pancreatic Cancer Imaging and Immunotherapy